Advertisement

Topics

ArcherDX, Inc. Company Profile

07:37 EDT 22nd June 2018 | BioPortfolio

ArcherDX, the NGS applications company, is developing and commercializing a novel approach to target enrichment chemistry. Next-generation sequencing technology based on Anchored Multiplexed PCR (AMP™) generates a highly enriched library of gene targets of interest for downstream genomic sequencing. Complemented by proprietary software and readily accessible reports, our technology enables dramatic enhancement in mutation detection speed as well as complex mutation identification and discovery. www.ArcherDX.com


News Articles [2 Associated News Articles listed on BioPortfolio]

ArcherDX brings in $35mm Series A round

ArcherDX Inc. (next-generation sequencing (NGS) gene fusion detection assays) raised $35mm through a Series A round co-led by Boulder Ventures (added a board member) and PBM Capital Group. New investo...

ArcherDX Closes $35 Million Series A Financing

The capital comes after a year of record growth for the company and penetration into liquid biopsy, immune sequencing, and companion diagnostic (CDx) markets. The Read more...

Drugs and Medications [0 Results]

None

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

ALK Gene Fusions in Epithelioid Fibrous Histiocytoma: A Study of 14 Cases, With New Histopathological Findings.

Previous studies showed that ALK is often positive in epithelioid fibrous histiocytoma (EFH). Two cases of EFH with ALK gene fusions have been recorded. Our objective was to study a series of EFH to p...

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

ArcherDX, Inc.

ArcherDX, the NGS applications company, is developing and commercializing a novel approach to target enrichment chemistry. Next-generation sequencing technology based on Anchored ...

PBM Capital Group, LLC

PBM Capital Group, LLC. is a private investment firm primarily focused on healthcare investments. Led by Paul Manning, a successful entrepreneur, the PBM Capital Group partners...

More Information about "ArcherDX, Inc." on BioPortfolio

We have published hundreds of ArcherDX, Inc. news stories on BioPortfolio along with dozens of ArcherDX, Inc. Clinical Trials and PubMed Articles about ArcherDX, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ArcherDX, Inc. Companies in our database. You can also find out about relevant ArcherDX, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...


Corporate Database Quicklinks



Searches Linking to this Company Record